Kiwon lafiyaShirye-shirye

"Femazh MPS nauyi iko ': Umarni, reviews

"Femazh MPS nauyi iko" manual bayyana yadda miyagun ƙwayoyi da aka tsara don daidaita nauyi a lokacin menopause a mata. Hakika, kowannenmu yana so ya zama siriri kuma kyau a kowane zamani, amma a kan lokaci shi ya zama da wuya da kuma wuya.

ganawa Kari

"Femazh MPS Weight Control" jagora ya bayyana a matsayin wani abin da ake ci kari don taimaka mata yãƙi kiba, matalauta kiwon lafiya da kuma rashin barci a lokacin menopause. Duk da haka, da yawa mata lura cewa, ko da idan ba ka canza a kullum da kuma motsa jiki, da karin nauyi ba kawai ba su tafi ba, amma kuma tara. Babban dalilin wannan sabon abu ne a dauke su a kaifi dakushe yawan mace hormone estrogen a cikin jiki. Saboda haka, cikin jiki yayi kokarin cika da wani yawan yiwu hanyoyin kamar yadda ya cancanta mace abubuwa, kuma, da ita qara yawan kitsen Kwayoyin a cikin mace jiki.

"Femazh MPS Weight Control" (jagora farashin da aka bayyana a cikin wannan labarin) taimaka wajen rayayye yaƙi da wuce haddi mai tarawa. A daidai wannan lokaci shi ba ka damar ba kawai kula da al'ada nauyi, amma kuma rage shi.

Wannan abin da ake ci kari iya sarrafa ka ci, kazalika da rage da kumburi na jiki da kuma gyara matsalar yankunan.

da miyagun ƙwayoyi

Abin da ake ci kari "Femazh MPS nauyi iko", da wa'azi ga wanda aka bayyana a baya, a wannan labarin, shi ne wani aiki hadaddun, akwai a capsules kasu kashi biyu:

  • Dare capsules kunshi kore shayi tsantsa, arginine da lysine. Wadannan abubuwa da cikakken kwayoyin maganin kafeyin, catechins, sauran amfani mahadi.

  • Rana capsules, wanda dauke da 'ya'ya ceri duwatsu da kuma meadowsweet da crithmum seaside. Wadannan aka gyara bunkasa lamarinsa mata a lokacin menopause da wadãtar da jiki da m muhimmanci mai da salicin.

Kowane bangaren na halitta kari da kawai na halitta asalin, saboda haka, za a iya zaton cikakken hadari ga mace jiki a lokacin menopause.

alamomi

Drug "Femazh MPS Weight Control" (Umarni a cikin labarin) bada shawarar a lokacin da bayyanar cututtuka irin su wuce haddi nauyi a lokacin menopause, illa metabolism, kumburi na jiki.

Doctors bayar da shawarar yin amfani da wannan ƙari a matsayin mai amfani Baya ga asali rage cin abinci. A kai a kai shan abin da ake ci kari, nan da nan za ka ga babban sakamako.

contraindications

Duk da cewa wannan kari da aka hada da kawai na halitta asalin aka gyara, ya kamata a yi amfani da tare da iyakar taka tsantsan. Akwai jerin contraindications cewa dole ne a karanta kafin amfani da kari:

  • alerji da aka gyara kunshe a cikin abun da ke ciki.
  • koda cuta.
  • zuciya da kuma jijiyoyin bugun gini cututtuka.
  • herpes.

"Femazh MPS nauyi iko": da wani umurni description

Don wannan shiri haifar da wata dace sakamako, wajibi ne a bi na musamman kewaye. Masana sun bada shawarar shan 'yan capsules kafin karin kumallo da kuma abincin dare. A lokacin da wannan shiri tsarkake bukatar sha ruwa, ko wasu abubuwan sha. Doctors bayar da shawarar da shan wannan abin da ake ci kari for kwana goma sha huɗu. Idan akwai wani gaggawa bukatar, za ka iya maimaita cikin shakka a shekara.

Capsules da wani mai sauqi qwarai amma tasiri mataki a kan mace jiki a lokacin menopause. Capsules ga rana amfani mai tarawa ne tuba zuwa aiki da makamashi da aka yi amfani a lokacin da rana. Rawa da kwantena rayayye karya saukar kitsen da bugun sama metabolism.

"Femazh MPS nauyi iko": Farashin, real likitoci da marasa lafiya

Daya fakitin Kudinsa BAA 1500 rubles. Duk da irin wannan babban kudin da miyagun ƙwayoyi ne a high bukatar. Reviews da marasa lafiya da mafi yawa kaffa. Daidai a metabolism, mai vuya, sabon bai bayyana.

Duk da haka, likitoci koma zuwa da kayan aiki tare da taka tsantsan, shi ne shawarar kawai a matsayin karshe mafaka. Bisa ga shawarwarin da likitoci, mata a menopause yi karin yanã tafiya a cikin sabo ne iska, motsa jiki da kuma ci lafiya abinci. Kuma a sa'an nan ba abin da ake ci kari ba su da ake bukata.

Similar articles

 

 

 

 

Trending Now

 

 

 

 

Newest

Copyright © 2018 ha.birmiss.com. Theme powered by WordPress.